HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q3 2021
Top Holdings85 positions
BEONE MEDICINES LTD | 5.5M | $2B | 26.0% | $136.90 | +165.17% | 12 qtrssince 2018-Q4 | Unchanged 0 |
LEGEND BIOTECH CORP | 11.1M | $558.9M | 7.3% | $46.85 | +0.77% | 6 qtrssince 2020-Q2 | Increased 99 |
I MAB | 7.2M | $520.7M | 6.8% | $47.24 | +50.76% | 5 qtrssince 2020-Q3 | Increased 66 |
ON HOLDING AG CL A | 16M | $481.3M | 6.3% | $30.90 | 0.00% | 1 qtr | New 97 |
JD.COM INC | 4.8M | $344.4M | 4.5% | $49.36 | +31.66% | 12 qtrssince 2018-Q4 | Increased 72 |
SALESFORCE INC | 1.3M | $340.2M | 4.4% | $190.38 | +39.80% | 7 qtrssince 2020-Q1 | Increased 63 |
IQIYI INC | 38.6M | $310.3M | 4.1% | $18.39 | -57.97% | 12 qtrssince 2018-Q4 | Unchanged 0 |
PDD HOLDINGS INC | 2.8M | $254.6M | 3.3% | $34.21 | +165.04% | 12 qtrssince 2018-Q4 | Decreased 0 |
BRIDGEBIO PHARMA INC | 5.4M | $251.3M | 3.3% | $28.25 | +68.54% | 10 qtrssince 2019-Q2 | Unchanged 0 |
DOORDASH INC | 1.2M | $246.4M | 3.2% | $141.95 | +45.01% | 4 qtrssince 2020-Q4 | Unchanged 0 |
CYTEK BIOSCIENCES INC | 8.8M | $187.5M | 2.5% | $21.41 | 0.00% | 1 qtr | New 79 |
BEAM THERAPEUTICS INC | 1.4M | $126M | 1.6% | $18.00 | +30.39%as of Oct 16 | 7 qtrssince 2020-Q1 | Decreased 0 |
MONDELEZ INTL INC | 1.9M | $108.3M | 1.4% | $33.70 | +57.03% | 12 qtrssince 2018-Q4 | Unchanged 0 |
ALIBABA GROUP HLDG LTD | 713,400 | $105.6M | 1.4% | $213.40 | -34.71% | 3 qtrssince 2021-Q1 | Unchanged 0 |
Sea Ltd | 330,000 | $105.2M | 1.4% | $311.78 | 0.00% | 1 qtr | New 68 |
ERASCA INC | 4.7M | $100.2M | 1.3% | $19.84 | 0.00% | 1 qtr | New 68 |
VIPSHOP HLDGS LTD | 9M | $99.9M | 1.3% | $18.58 | -45.90% | 3 qtrssince 2021-Q1 | Unchanged 0 |
GOSSAMER BIO INC | 7.4M | $93.3M | 1.2% | $1,330.85 | -24.44% | 11 qtrssince 2019-Q1 | Unchanged 0 |
KE HLDGS INC | 5M | $91.5M | 1.2% | $56.88 | -70.21% | 5 qtrssince 2020-Q3 | Unchanged 0 |
PLAYTIKA HOLDING CORP | 3.3M | $90.6M | 1.2% | $23.03 | -0.35% | 3 qtrssince 2021-Q1 | Unchanged 0 |
HHLR ADVISORS, LTD. manages $7.6B across 85 positions as of Q3 2021. Top holdings: ONC (26.0%), LEGN (7.3%), NBP (6.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
Active quarter - 21 new positions, 25 exits, 5 increased. Top move: LEGN (INCREASED, conviction 99). Portfolio: $7.6B across 85 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR